IL15 and neoplasm: Recent approaches involve targeted delivery of IL-15 to T cells that may be enriched for antigen specificity capable of mediating anti-tumor immunity, thereby enhancing the therapeutic benefit of IL-15 based therapies (Martomo et al., 2021; Xu et al., 2021; Shen et al., 2022).